Changeflow GovPing Healthcare Abbott ID NOW Influenza A & B 2 Recall - Higher...
Urgent Enforcement Amended Final

Abbott ID NOW Influenza A & B 2 Recall - Higher Invalid Rates, Z-1565-2026

Favicon for changeflow.com FDA: Device Recalls Class II
Filed
Detected
Email

Summary

FDA announced a Class II recall of Abbott Diagnostics Scarborough, Inc. ID NOW Influenza A & B 2 test kits (Model/Catalog Number: 427-000). The recall affects products with a higher occurrence of invalid rates compared to product Instructions for Use. Distribution was nationwide in the United States. The recall is ongoing.

What changed

FDA issued a Class II recall for Abbott ID NOW Influenza A & B 2 test kits after confirming that impacted lots exhibited higher invalid rates than specified in the product Instructions for Use. The recall applies to Model/Catalog Number 427-000 distributed nationwide in the United States.\n\nHealthcare providers and laboratories using these test kits should immediately identify any remaining inventory of affected lots, discontinue use, and contact Abbott Diagnostics Scarborough directly for return and replacement instructions. Patients who received potentially invalid test results may need to be retested. The recall is classified as ongoing.

What to do next

  1. Identify and quarantine affected lot numbers of ID NOW Influenza A & B 2 (427-000)
  2. Contact Abbott Diagnostics Scarborough for return/replacement instructions
  3. Report any adverse events related to invalid test results

Archived snapshot

Apr 11, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Abbott Diagnostics Scarborough, Inc.

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1565-2026 · 20260325 · Ongoing

Product

Product Name: ID NOW" Influenza A & B 2 Model/Catalog Number: 427-000 Software Version: Not Applicable Product Description: Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique Com...

Reason for Recall

It was confirmed that the impacted lot has a higher occurrence of invalid rates when compared to the product Instructions for Use.

Distribution

US Nationwide distribution.

Source: openFDA Enforcement API

Named provisions

Product - ID NOW Influenza A & B 2 Reason for Recall Distribution

Get daily alerts for FDA: Device Recalls Class II

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 25th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1565-2026

Who this affects

Applies to
Medical device makers Healthcare providers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
In vitro diagnostic testing Point-of-care testing Influenza diagnostics
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Public Health Product Safety

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!